EPITHELIAL OVARIAN CANCER
Clinical trials for EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer drug trial halted after testing in just 3 patients
Disease control TerminatedThis was a very early, first-in-human study to test the safety and find the right dose of an experimental drug called AMG 794. It was for adults with advanced or spreading cancers that have a specific marker called Claudin 6 (CLDN6), including certain lung and ovarian cancers. Th…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New hope for women battling Tough-to-Treat ovarian cancer?
Disease control TerminatedThis study tested an experimental drug called luveltamab tazevibulin against standard chemotherapy for women with advanced ovarian cancer that had returned and stopped responding to platinum-based drugs. It aimed to see if the new drug could better control the cancer and improve …
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE2, PHASE3 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC